Clinical Trials Logo

Milk Intolerance clinical trials

View clinical trials related to Milk Intolerance.

Filter by:
  • None
  • Page 1

NCT ID: NCT05305391 Completed - Milk Intolerance Clinical Trials

Low-grade Inflammation and Gut Symptoms From A2 and Hydrolyses A1 Milk

Start date: May 18, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to reveal how different forms of milk casein, lactose and moderate breakdown of proteins affect the symptoms that may arise from milk and markers of inflammation in volunteers receiving symptoms from milk. Research hypotheses are: 1) Protein hydrolyzed milk is as tolerated or better tolerated than A2 milk, and 2) Lactose is the main causative agent of stomach symptoms in milk-sensitive individuals.

NCT ID: NCT03060395 Completed - Milk Intolerance Clinical Trials

Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

There is increasing evidence that a number of people experience moderate milk intolerance characterised by increased gas production, bloating and abdominal cramp, which can neither be attributed to lactose intolerance, nor to milk protein allergy. Milk digestion can lead to the formation of bioactive peptides, one of which derived from a mutated gene variant (A1) coding for milk beta-casein has been associated with increased gastrointestinal inflammation and poor gastrointestinal function. In this study, we hypothesise that consumption of non-mutated A2 milk will improve gastrointestinal symptoms in non-lactose milk intolerant individuals.